Ovoca Bio PLC
LSE:OVB
Ovoca Bio PLC
LSE:OVB
Price:
0.9 GBX
Updated:
Jun 3, 2024
Ovoca Bio PLC
Cash from Financing Activities
|
Ovoca Bio PLC
Cash from Financing Activities Peer Comparison
Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Financing Activities
€888k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Financing Activities
-$196.9m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Financing Activities
-$305.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Financing Activities
$114.1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Financing Activities
-$204k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Financing Activities
-€209.3m
|
CAGR 3-Years
-160%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Ovoca Bio PLC's Cash from Financing Activities?
Cash from Financing Activities
888k
EUR
888k
EUR
Based on the financial report for Jun 30, 2023, Ovoca Bio PLC's Cash from Financing Activities amounts to 888k EUR.
What is Ovoca Bio PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-9%
-9%
Over the last year, the Cash from Financing Activities growth was 29 500%.
You don't have any saved screeners yet
